KNOXVILLE, Tenn.--(BUSINESS WIRE)--Provectus Pharmaceuticals, Inc. (OTC BB: PVCT, http://www.pvct.com), a development-stage oncology and dermatology biopharmaceutical company, has appointed Alfred E. Smith IV to its Board of Directors, increasing the number of independent members of the Board as it further strengthens its Corporate Governance.
